272 Capital’s SkinHealth Systems SKIN Stock Holding History

272 Capital’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,290	Closed	-$782K	–	99
2023 Q4	$782K	Buy	9,290 +9,120	+5,365%	+$684K	0.26%	59
2023 Q3	$20.5K	Buy	+170	New	+$23.9K	0.01%	62

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

LCG

Luxor Capital Group New York $2.52B AUM 29.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

272 Capital's SKIN Position: Q1 2024 in Review

272 Capital sold out of SkinHealth Systems (SKIN) in Q1 2024, closing a stake of 9,290 shares — an estimated $782K sold.

272 Capital first reported a position in SKIN in Q3 2023 and held it in 2 quarters. The position peaked at $782K in Q4 2023. 120 funds tracked by Wall St. Rank hold SKIN as of Q1 2024.

272 Capital reported no remaining SkinHealth Systems position as of Q1 2024 after selling out during the quarter.
272 Capital sold 9,290 SkinHealth Systems shares in Q1 2024, an estimated $782K.
272 Capital first reported a position in SkinHealth Systems in Q3 2023 and held it in 2 quarters.
272 Capital's SkinHealth Systems position peaked at $782K in Q4 2023.
120 funds tracked by Wall St. Rank held SkinHealth Systems as of Q1 2024.

Based on 272 Capital's 13F filing for Q1 2024, filed 15 May 2024.